| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 06/02/2000 | WO2000031128A1 Chimeric biotin-binding papillomavirus protein |
| 06/02/2000 | WO2000030668A2 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration |
| 06/02/2000 | WO2000030667A2 Compositions and methods using lactadherin or variants thereof |
| 06/02/2000 | WO2000008131A3 Pseudotyped retroviruses and stable cell lines for their production |
| 06/02/2000 | CA2352458A1 Compositions and methods using lactadherin or variants thereof |
| 06/02/2000 | CA2352043A1 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration |
| 06/02/2000 | CA2351741A1 Vectors for gene mutagenesis and gene discovery by gene trapping |
| 06/02/2000 | CA2351630A1 Vector |
| 06/02/2000 | CA2351614A1 Chimeric biotin-binding papillomavirus protein |
| 05/31/2000 | EP1004664A1 Compositions and methods using lactadherin or variants thereof |
| 05/31/2000 | EP1003894A2 Lentiviral vectors |
| 05/31/2000 | EP1003878A2 Hiv-1 group o antigens and uses thereof |
| 05/31/2000 | EP1003859A1 Use of transcription factor brn-3a |
| 05/31/2000 | EP1003841A1 Establishment of hhv-8+ lymphoma cell line, virus produced, antibody, diagnostic method and kit for detecting hhv-8 infection |
| 05/31/2000 | EP1003534A1 Reovirus for the treatment of neoplasia |
| 05/31/2000 | EP1003533A1 Use of herpes vectors for tumor therapy |
| 05/31/2000 | EP1003527A1 Polynucleotide compositions |
| 05/31/2000 | CN1255140A An infections clone for human parainfluenza virus type 3 |
| 05/31/2000 | CN1254756A Attenuated virus of ox's viral diarrhea |
| 05/31/2000 | CN1254719A Defective adenovirus and its building-up method |
| 05/31/2000 | CN1053012C Hog choera virus vaccine and diagnostic |
| 05/25/2000 | WO2000029626A1 Rhadino virus lana acts in trans on a unit of rhadino virus dna to mediate efficient episome persistence |
| 05/25/2000 | WO2000029599A1 Viral vectors with late transgene expression |
| 05/25/2000 | WO2000029598A1 Novel recombinant adenovirus |
| 05/25/2000 | WO2000029561A2 Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope |
| 05/25/2000 | WO2000029557A1 A sensitive screening system for envelope-defective recombinant virus |
| 05/25/2000 | WO2000029556A2 Identification of glycosphingolipids that promote hiv-1 entry into cells |
| 05/25/2000 | WO2000029421A1 Selection system for generating efficient packaging cells for lentiviral vectors |
| 05/25/2000 | WO2000014205A3 Methods for generating high titer helper-free preparations of released recombinant aav vectors |
| 05/25/2000 | WO2000008194A3 Cell lines for the propagation of mutated herpes viruses |
| 05/25/2000 | CA2803417A1 Selection system for generating efficient packaging cells for lentiviral vectors |
| 05/25/2000 | CA2369119A1 Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope |
| 05/25/2000 | CA2351314A1 Novel recombinant adenovirus |
| 05/25/2000 | CA2350124A1 A sensitive screening system for envelope-defective recombinant virus |
| 05/24/2000 | EP1002120A1 Chimeric adenoviral vectors |
| 05/24/2000 | EP1002091A1 Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue |
| 05/24/2000 | EP1002066A1 Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces |
| 05/24/2000 | EP1002055A1 Recovery of virus from cell culture using a hypertonic salt solution |
| 05/24/2000 | EP1002054A1 Process for the production of virus in cell cultures |
| 05/24/2000 | EP1001795A1 Vasoprotective recombinant adenovirus vector containing a human tfpi gene |
| 05/23/2000 | US6066783 Genes encoding insecticidal proteins |
| 05/23/2000 | US6066498 Compositions for the treatment and diagnosis of immune disorders |
| 05/23/2000 | US6066478 Dna encoding a hybrid protein including a recombinase able to recognize a recombination sequence and a linking region recognized by a ligand; for complementation cells used to produce viral vectors used in gene therapy |
| 05/23/2000 | US6066324 Carboxyl terminal of papilloma virus L1 region is not required for formation of virus-like particles |
| 05/23/2000 | US6066322 Administering antibody to treat asthma; treating helper t-cell mediated conditions |
| 05/23/2000 | CA2290197A1 Vaccine against swine influenza virus |
| 05/23/2000 | CA2066998C Recombinant varicella-zoster virus and process for constructing same |
| 05/18/2000 | WO2000028059A1 Adenovirus-mediated gene therapy |
| 05/18/2000 | WO2000028040A2 Cloning of rhadinovirus genome and methods for its use |
| 05/18/2000 | WO2000028039A2 Identification of senv genotypes |
| 05/18/2000 | WO2000028009A1 Biological compositions, components thereof and uses therefor |
| 05/18/2000 | WO2000028004A1 Virus vectors and methods of making and administering the same |
| 05/18/2000 | WO2000028003A1 Avipox vector coding an hiv antigen and a cytokine |
| 05/18/2000 | WO2000009730A3 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins |
| 05/18/2000 | WO2000009699A3 Method for producing yeast expressed hpv types 6 and 16 capsid proteins |
| 05/18/2000 | WO2000008193A3 Latency-active regulatory sequences of herpesviruses and latency-inactive herpesvirus for gene transfer |
| 05/18/2000 | CA2348382A1 Chimeric parvovirus vectors and methods of making and administering the same |
| 05/17/2000 | EP1001032A2 Recombinant retroviruses delivering vector constructs to target cells |
| 05/17/2000 | EP1001030A1 Recombinant CELO virus and CELO virus DNA |
| 05/17/2000 | EP1000157A1 Homogeneous human papilloma virus capsomere containing compositions, methods for manufacture, and the use thereof as diagnostic, prophylactic or therapy |
| 05/17/2000 | CN1253506A Chimeric flavirirus vaccines |
| 05/17/2000 | CN1253176A Composition and method for protecting animals from diseases related with slow action virus |
| 05/16/2000 | US6063628 Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA |
| 05/16/2000 | US6063622 Adenovirus vectors |
| 05/16/2000 | US6063610 Flea hydrolase enzyme; for development of antibodies to prevent parasitic infection of plant and animals |
| 05/16/2000 | US6063608 Cloned genes encoding reverse transcriptase lacking RNase H activity |
| 05/16/2000 | US6063374 Administering hybrid gene |
| 05/11/2000 | WO2000026667A1 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha |
| 05/11/2000 | WO2000026395A2 Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors |
| 05/11/2000 | WO2000026246A2 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof |
| 05/11/2000 | WO2000008043A3 Prevention and treatment of viral disease |
| 05/11/2000 | WO2000007618A3 Anti-apoptotic compositions comprising the r1 subunit of herpes simplex virus ribonucleotide reductase or its n-terminal portion; and uses thereof |
| 05/11/2000 | CA2349410A1 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof |
| 05/11/2000 | CA2317808A1 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha |
| 05/10/2000 | EP0999281A1 Non-nuclear chromosomal transformation |
| 05/10/2000 | EP0999279A1 Gene transfer method with the use of serum-free medium |
| 05/10/2000 | EP0998576A2 Bovine adenovirus type 3 genome |
| 05/10/2000 | EP0998568A1 Mutant having uracil phosphoribosyl transferase activity |
| 05/10/2000 | CN1252840A Adenovirus vector specific for cells expressing alpha fetoprotein and methods of use thereof |
| 05/10/2000 | CN1252687A Improved storage and maintenance of blood products |
| 05/10/2000 | CN1252450A Construction and application of serial universal adenovirus accompanying virus carriers |
| 05/10/2000 | CN1252441A Recombined-adenovirus accompanying virus production method and application |
| 05/10/2000 | CN1252309A Stabilizer-containing live attenuated hepatitis A vaccine and its preparation |
| 05/10/2000 | CA2287775A1 Attenuated forms of bovine viral diarrhea virus |
| 05/09/2000 | US6060595 Inhibition of viral replication |
| 05/09/2000 | US6060280 Nucleotide sequences encoding bovine respiratory syncytial virus immunogenic proteins |
| 05/04/2000 | WO2000024916A1 Improved aav vector production |
| 05/04/2000 | WO2000024876A2 Spumavirus isolated from humans |
| 05/04/2000 | WO2000024420A1 Method for the production of an antiviral agent |
| 05/04/2000 | WO2000024408A1 Method for killing tumor and tumor associated endothelial cells using adenoviral mutants |
| 05/04/2000 | WO2000012741A3 Inducible expression system |
| 05/04/2000 | WO2000002909A3 Amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins |
| 05/04/2000 | WO1999051781A9 Hepatitis c virus ns5b compositions and methods of use thereof |
| 05/04/2000 | WO1999047660A9 Retroviral packaging cell line |
| 05/04/2000 | DE19916085A1 Antiviral agent, e.g. for treating HIV infections, comprising autovaccine obtained by heating blood containing viruses and antigens with protein crosslinking agent |
| 05/04/2000 | CA2348840A1 Method for the production of an antiviral agent |
| 05/04/2000 | CA2348838A1 Improved aav vector production |
| 05/04/2000 | CA2348634A1 Methods for killing tumor and tumor associated endothelial cells using adenoviral mutants |
| 05/03/2000 | EP0997529A2 Feline immunodeficiency virus strain FIV-141 and uses thereof |
| 05/03/2000 | EP0996738A1 Recombinant vector containing infectious, viral genome sequences greater than 100 kb, method for producing same and use for the mutagenesis of the viral sequences |